Infectious diseases. DNA sleuths track C. difficile infection routes.
Gunjan
G
Sinha
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D058345:Asymptomatic Infections / Q000453:epidemiology; D002353:Carrier State / Q000175:diagnosis / Q000453:epidemiology* / Q000382:microbiology; D016360:Clostridioides difficile / Q000235:genetics*; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission*; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics*; D011307:Drug Prescriptions / Q000592:standards* / Q000706:statistics & numerical data; D004739:England / Q000453:epidemiology; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D017053:Infection Control / Q000191:economics / Q000379:methods; D007902:Length of Stay / Q000706:statistics & numerical data; D015995:Prevalence
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial